KROS - Keros Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

512.4M

Cash

322M

Avg Qtr Burn

-27.78M

Short % of Float

5.54%

Insider Ownership

7.76%

Institutional Own.

93.74%

Qtr Updated

06/30/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
KER-012 Details Pulmonary hypertension, Cardiovascular disease	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KER-050 Details Blood cancer, Cystic fibrosis, Lung disease, Myelofibrosis, Cancer	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KER-050 Details Blood disorder, Cancer, Myelodysplastic syndrome	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KER-065 Details Duchenne muscular dystrophy, Neuromuscular disease	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KER-047 (ALK2 inhibitor) Details Myelodysplastic syndrome, Myelofibrosis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KER-047 (ALK2 inhibitor) Details Fibrodysplasia ossificans progressiva, Anemia	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.